‘They rushed the process’: Vaccine maker’s woes hamper global inoculation campaign

.cms-textAlign-left{text-align:left;}.cms-textAlign-center{text-align:center;}.cms-textAlign-right{text-align:right;}.cms-magazineStyles-smallCaps{font-variant:small-caps;}

The world’s vaccine distributor has been counting on U.S. companies to provide more than 2 billion doses to lower and middle-income countries by the end of 2022 — a crucial step in ending the Covid-19 pandemic.

But the campaign run by the international consortium known as COVAX, which has already been delayed significantly because of production lags, is now likely to fall short by more than 1 billion doses as a key supplier faces significant hurdles in proving it can manufacture a shot that meets regulators’ quality standards, according to three people with direct knowledge of the company’s problems.

The delay, which was confirmed by three

Facebook Notice for EU!
You need to login to view and post FB Comments!

→ Continue reading at Politico

[ufc-fb-comments url="http://www.newyorkmetropolitan.com/news/they-rushed-the-process-vaccine-makers-woes-hamper-global-inoculation-campaign"]

Latest Articles

Related Articles